The Brexit Countdown: Is there still an Opportunity for Conducting Clinical Trials in the UK?
Malcolm Thomas, Agile Sciences Inc., debates some of the regulatory challenges that Brexit may pose for those companies seeking to initiate clinical trials in the U.K.
